BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Celecoxib

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

488+ PubMed studies analyzed · 91 RCTs · Evidence Score: 60.3

Research Domains

Celecoxib has been studied across 16 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology, 💊 Pain, 😴 Sleep. The primary research focus is 🔬 Inflammation with 44% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Celecoxib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Daunorubicin
35 shared targets
Valproic
19 shared targets
Resveratrol
34 shared targets
Flutamide
24 shared targets
Lynestrenol
21 shared targets
Sulfanilamide
17 shared targets
Ethinyl
27 shared targets
Indapamide
17 shared targets
o-Phthalaldehyde
19 shared targets
Danazol
23 shared targets
Loading evidence profile...

This evidence profile for Celecoxib is generated deterministically from 488 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.